Texas HB 1874: Relating to a regenerative medicine registry established by the Texas Regenerative Medicine Coordinating Board.

Bill Text

By:AADavis of Harris H.B.ANo.A1874
A BILL TO BE ENTITLED
AN ACT
relating to a regenerative medicine registry established by the
Texas Regenerative Medicine Coordinating Board.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTIONA1.AAThe heading to Chapter 156, Education Code, is
amended to read as follows:
CHAPTER 156. REGENERATIVE MEDICINE [ADULT STEM CELL RESEARCH]
PROGRAM
SECTIONA2.AASections 156.001(2) and (4), Education Code, are
amended to read as follows:
(2)AA"Consortium" means the Texas Regenerative
Medicine [Adult Stem Cell Research] Consortium.
(4)AA"Program" means the regenerative medicine [adult
stem cell research] program established under this chapter.
SECTIONA3.AASection 156.001(5), Education Code, is
redesignated as Section 156.001(3-a), Education Code, and amended
to read as follows:
(3-a)AA"Medical [(5) "Research] coordinating board"
means the Texas Regenerative Medicine [Adult Stem Cell Research]
Coordinating Board.
SECTIONA4.AASection 156.002, Education Code, is amended to
read as follows:
Sec.A156.002.AACOMPOSITION OF MEDICAL [RESEARCH]
COORDINATING BOARD. (a) The Texas Regenerative Medicine [Adult
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
86R9709SCL-D 1

Stem Cell Research] Coordinating Board is composed of seven members
appointed as follows:
(1)AAthree members who are interested persons,
including at least one person who represents an institution of
higher education and one person who is a representative of an
advocacy organization representing patients, appointed by the
governor, with the advice and consent of the senate;
(2)AAtwo members who are interested persons appointed
by the lieutenant governor; and
(3)AAtwo members who are interested persons appointed
by the speaker of the house of representatives.
(b)AAThe governor shall designate as the presiding officer of
the medical [research] coordinating board a board member appointed
under Subsection (a)(1) who represents an institution of higher
education. The presiding officer serves in that capacity at the
will of the governor.
(c)AAThe members of the medical [research] coordinating
board serve staggered six-year terms. If a vacancy occurs on the
board, the appropriate appointing authority shall appoint, in the
same manner as the original appointment, another person to serve
for the remainder of the unexpired term.
SECTIONA5.AASections 156.003(b) and (c), Education Code, are
amended to read as follows:
(b)AAA person may not be a member of the medical [research]
coordinating board if:
(1)AAthe person is an officer, employee, or paid
consultant of a Texas trade association in the field of medicine;
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
H.B.ANo.A1874
2

(2)AAthe person’s spouse is an officer, manager, or paid
consultant of a Texas trade association in the field of medicine; or
(3)AAthe person is a member of the Texas Higher
Education Coordinating Board.
(c)AAA person may not be a member of the medical [research]
coordinating board if the person is required to register as a
lobbyist under Chapter 305, Government Code, because of the
person’s activities for compensation on behalf of a profession
related to the operation of the board.
SECTIONA6.AASection 156.004(a), Education Code, is amended
to read as follows:
(a)AAThe medical [research] coordinating board shall
establish the Texas Regenerative Medicine [Adult Stem Cell
Research] Consortium.
SECTIONA7.AASection 156.005, Education Code, is amended to
read as follows:
Sec.A156.005.AAADMINISTRATION OF PROGRAM; GUIDELINES AND
PROCEDURES. (a) The medical [research] coordinating board shall
administer the program to:
(1)AAmake grants and loans to consortium members for:
(A)AAadult stem cell research projects, including
projects to develop therapies, protocols, or medical procedures
involving adult stem cells;
(B)AAthe development of facilities to be used
solely for adult stem cell research projects; and
(C)AAthe commercialization of products or
technology involving adult stem cell research and treatments;
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
H.B.ANo.A1874
3

(2)AAsupport consortium members in all stages of the
process of developing treatments and cures based on adult stem cell
research, beginning with initial laboratory research through
successful clinical trials;
(3)AAestablish appropriate regulatory standards and
oversight bodies for:
(A)AAadult stem cell research conducted by
consortium members; and
(B)AAthe development of facilities for consortium
members conducting adult stem cell research; and
(4)AAassist consortium members in applying for grants
or loans under the program.
(b)AAThe medical [research] coordinating board shall develop
research priorities, guidelines, and procedures for providing
grants and loans for specific research projects conducted by
consortium members. The priorities, guidelines, and procedures
must require the grants and loans to be made on a competitive, peer
re